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BACKGROUND: Cervical cancer is the third most common malignancy affecting women. Screening with
Papanicolaou (Pap) tests effectively identifies precancerous lesions and early-stage cervical cancer. While the
nationwide rate of cervical cancer screening (CCS) is
84%, our urban general internal medicine (GIM) clinic
population had a CCS rate of 70% in 2016.
OBJECTIVE: To improve our clinic’s CCS rate to match or
exceed the national average within 18 months by identifying barriers and testing solutions.
DESIGN: A quality improvement project led by a multidisciplinary group of healthcare providers.
PARTICIPANTS: Our GIM clinic includes 16 attending
physicians, 116 resident physicians, and 20 medical assistants (MAs) with an insured and underserved patient
population.
INTERVENTION: Phase 1 lasted 9 months and implemented CCS patient outreach, patient financial incentives, and clinic staff education. Phase 2 lasted 9 months
and involved a workflow change in which MAs identified
candidates for CCS during patient check-in. Feedback
spanned the entire study period.
MAIN MEASURES: Our primary outcome was the number of Pap tests completed per month during the 2 study
phases. Our secondary outcome was the clinic population’s CCS rate for all eligible clinic patients.
KEY RESULTS: After interventions, the average number
of monthly Pap tests increased from 35 to 56 in phase 1
and to 75 in phase 2. Of 385 patients contacted in phase
1, 283 scheduled a Pap test and 115 (41%) completed it.
Compared to baseline, both interventions improved cervical cancer screening (phase 1 relative risk, 1.86; 95% CI,
1.64–2.10; P < 0.001; phase 2 relative risk, 2.70; 95% CI,
2.40–3.02; P < 0.001). Our clinic’s CCS rate improved
from 70% to 75% after the 18-month intervention.
CONCLUSIONS: The rate of CCS increased by 5% after a
systematic 2-phase organizational intervention that
empowered MAs to remind, identify, and prepare candidates during check-in for CCS.
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INTRODUCTION

Worldwide, cervical cancer is the third most common malignancy affecting women. Screening with a Papanicolaou (Pap)
test has decreased the incidence of invasive cervical cancer. In
areas where cervical cancer screening (CCS) rates are low,
cervical cancer deaths remain high.1 CCS rates are defined as
the percentage of eligible women aged 21–64 years who
complete CCS using a year-to-date or rolling 12 month average and are based on Healthcare Effectiveness and Data Information Set (HEDIS) measures.2 The US Office of Disease
Prevention and Health Promotion’s Healthy People 2020 goal
for CCS is 93%3; however, the CCS rate nationwide in 2016
was 84.2%, and was even less for African American women.4,5 In 2016, our urban academic general internal medicine
(GIM) clinic had a low CCS rate of 70%, thus prompting an
intervention.
A review of the literature shows many effective approaches
for increasing cancer screening, including healthcare provider
education,6 patient reminders,7–15 provider feedback,10,16,17
elimination of structural barriers,7,18 involving non-physician
staff,11,19–23 scheduling separate preventive visits,22,24 organizational change,5 and combining multiple strategies at once.25
Shifting top of license responsibilities from physicians to other
members of the care team, such as medical assistants (MAs),
has been reported to improve quality of patient care.26–29
Based on these findings, we formed a multidisciplinary group
to design an intervention to improve the CCS rate in our clinic
to match the nationwide US rate within 18 months.
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METHODS

Led by a multidisciplinary team, this quality improvement
study used Lean tools to identify barriers to CCS in clinic
and target areas for intervention. The study proposal was
reviewed by our institutional review board, and was determined to be exempt from full review, as it was a quality
improvement project and did not meet criteria for human
subjects research by the Revised Common Rule. We followed
the SQUIRE guidelines in the reporting of this study.30
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it took time for the patient to gown for CCS and for the
MA to retrieve supplies from the supply room.
To address the first 3 identified barriers (patient awareness,
cost, and provider knowledge), the first 9-month phase of our
intervention implemented patient outreach, financial incentives, and provider education. The second 9-month phase
targeted the fourth identified barrier (increased length of visit)
and involved a workflow change to allow for early identification of patients overdue for CCS and to shift this task from
physicians to MAs.

Setting
Our urban academic GIM clinic comprises 16 faculty, 116
resident physicians, 20 MAs, and 6 nurses. The MA full-time
equivalent (FTE) is 0.73 per 1.0 physician FTE. Annual clinic
volume is about 40,000 visits, the majority of which are for
chronic disease management, as 22% of our patients have
diabetes and 61% have hypertension. The majority (74%) of
our patients are African American. All patients seen in our
clinic are insured, with approximately 46% commercial, 16%
Medicare, 24% Medicare Advantage, and 14% Medicaid.
Prior to our intervention, patients overdue for CCS were
contacted 1 to 2 times per year through the electronic portal
with letters or by up to 3 telephone calls, after which they were
considered lost to follow-up. Approximately half of our patients enrolled in the electronic portal. Education on CCS
occurred during the patient clinic encounters and by displays
in exam rooms. Provider-level CCS rates were reviewed with
physicians twice yearly using a web-based dashboard. We
used the electronic medical record (EMR) Epic, which includes alerts to patients and providers when patients are overdue for CCS.
Prior to our intervention, providers identified and offered
CCS to patients who were overdue at the end of a visit. If
patients were agreeable, the MA would retrieve and set up
equipment, and then the provider and MA would reenter the
room together to complete the Pap test. Training of residents
included a checklist of how to perform a Pap test and practice
on a simulation model during onboarding. At minimum, the
first 5 Pap tests performed by residents required direct supervision per our institutional policy.

Intervention
Our intervention was designed by a multidisciplinary
group of MAs, nurses, and faculty and resident physicians
using Lean methods to identify areas for improvement
through discussion and by asking our colleagues for input.
The barriers identified included patient awareness, cost of
visits (including the cost of parking and co-pays), provider
knowledge of CCS (as approximately 60% of visits are
with resident physicians), and time. CCS extended the
length of the clinic visit, which is already time pressured.
This was thought to occur because identification of overdue patients by the provider occurred late in the visit and

Phase 1: Outreach, Education, and Financial Incentives.
We identified patients who were overdue for CCS using our
EMR and selected those who had visits in the last 2 years who
were paneled to physicians in our group with low CCS rates.
An MA called patients using a standard script to inform them
that they were overdue for CCS and offered them a visit for a
Pap test including a parking voucher. Patients who indicated
that they had a Pap test at an outside facility were asked to
have their records faxed. Patients were provided Pap-only
visits focusing on CCS and were billed as preventive visits
to eliminate co-pays. Small signs were put at the front desk
that advertised our women’s health services to improve patient
awareness.
All physicians were reeducated on indications for CCS, the
role of human papillomavirus (HPV) testing, Pap technique,
EMR billing, and documentation procedures using
PowerPoint presentations during regular staff meetings. Feedback on the number of Pap tests completed each month was
provided to all team members including physicians, MAs,
nurses, and secretaries by monthly emails and at staff meetings. Feedback on CCS rate was given quarterly. Data were
trended over time and stratified by clinic group. The feedback
portion continued throughout the intervention, including
phase 2.
Phase 2: Workflow Change. This intervention assigned MAs
to identify candidates for CCS from an EMR prompt during a
patient’s check-in process (Fig. 1). Patients were asked, using
standard scripting, if they were amenable to a Pap test during
that visit if time allowed. If the patient agreed, the MA directed
the patient to undress from the waist down, the patient was
provided a gown and sheet, and a tray was retrieved that was
used to set up supplies. When the time came for the Pap test,
the MA re-entered the room when the physician was ready and
prepared supplies. If the patient declined, the MA informed the
physician team by notation in the EMR.
To support this intervention, we ensured that all Pap supplies were available in each exam room, except for trays due to
limited supply. This meant that the MA simply had to enter the
room when the patient was ready and set up the tray while the
patient was being positioned. We opted for this workflow to
reduce any waste of supplies in case the Pap test was not
completed. The switch to MAs for identifying overdue
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Figure 1 Organizational intervention (phase 2). By having MAs identify candidates for CCS, we were able to allow workflow to be expedited to
save patient and provider time. Abbreviations: CCS, cervical cancer screening; MA, medical assistant; Pap, Papanicolaou.

patients for CCS was implemented through brief presentations
at division meetings, email reminders, and discussion during
our multidisciplinary huddles.

screening at age < 30, and more frequent intervals than recommended. However, we used the intervals of 2.5 years for
cytology and 4.5 years for HPV testing, as it is considered
acceptable by our health system to perform CCS in patients
who will be overdue in the next 6 months.

Outcome Measures
For the 18-month intervention, we measured the number of
CCS completed in our clinic each month. We calculated a
CCS rate which is defined as the percent of CCS completed in
eligible women empaneled to the clinic and is based on
HEDIS measures using a 12-month rolling denominator of
CCS due in the entire eligible clinic panel population. Eligible
women were age 21–64 years and had no history of hysterectomy, had not received a CCS with cytology in the prior 3
years, or for those over 30, a CCS with cytology plus HPV
testing in the prior 5 years. As the study period progressed, the
number of women overdue for CCS decreased due to routine
Pap testing. To account for this reduction in denominator, we
calculated a CCS completion index representing the proportion of the CCS completed in our clinic relative to the total
remaining CCS due in the panel population at the end of each
intervention period. While the number of Pap tests completed
and the CCS rate were looked at throughout the intervention,
the CCS completion index was calculated after the intervention. All data were extracted from our EMR, which automatically updated when CCS was done in our health system.
When CCS was done elsewhere, providers were encouraged
to manually update the EMR after obtaining records. We also
tracked the number of referrals to obstetrics/gynecology (OB/
GYN).
To ensure that our intervention did not increase low-value
care, we performed a random chart audit of patients with CCS
before and during the intervention. We defined low-value care
in accordance with the American College of Physicians31 as
CCS performed in patients < 21 years, ≥ 65 years with prior
appropriate screening, women with total hysterectomy, HPV

Statistical Analysis
Overall CCS rates were calculated for the following three
periods: pre-intervention, phase 1, and phase 2. The relative
risks, as the ratio of CCS rates from different periods, and 95%
CI were computed to evaluate the effectiveness of the interventions. Interrupted time series analysis adjusted for temporal
dependency was also conducted retrospectively to assess the
intervention effect, both immediately and over time. The
relative risks (RR) and 95% CIs were calculated to evaluate
the effects of outreach and workflow interventions compared
to baseline. A P < 0.05 was considered statistically significant.
Chi-square tests were used to determine the difference. Statistical analysis was done at the end of the study. All data
analysis was performed using SAS 9.4 (SAS Institute, Cary,
NC, USA).

RESULTS

In the 15 months prior to our intervention, 541 Pap tests were
completed in our clinic, averaging 36 per month (Fig. 2), and
the CCS rate was 70%. The CCS completion index was
2.86%.
During phase 1 of our intervention, which spanned 9
months, 563 telephone calls were made to 385 patients identified as overdue for CCS. The average age of patients overdue
for CCS was 42 years, of which 78% were African American,
13% White, and 9% other. A total of 283 (73%) appointments
were scheduled, of which 80 (28%) were cancelled, 87 (31%)
were no-show, and 115 (41%) completed their appointments.
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Figure 2 Number of Pap tests completed and due. The number of Pap tests completed increased throughout our intervention, while the number
of Pap tests due decreased. Abbreviations: Pap, Papanicolaou.

The number of referrals to OB/GYN decreased from 610 in the
9 months pre-intervention to 474 in phase 1 and 518 in phase
2. The number of clinic appointments available remained
relatively constant. After outreach and workflow interventions, the number of Pap tests completed increased, with a
more significant increase seen with workflow change in phase
2 compared to phase 1 (RR, 1.45; 95% CI, 1.29–1.63; P <
0.001).
Interrupted time series analysis indicated overall significant
variation between intervention periods (P = 0.013). After
implementation of each intervention, we observed immediate
improvement of the CCS rates, with sustained improvement
during phase 2 but not in phase 1 (Fig. 4). There was a trend
toward increasing CCS rate in the end of the pre-intervention
phase. The observed CCS rate of 4.27% at the end of the phase
1 was lower than the predicted rate of 4.92% based on preintervention trends. The CCS completion rate at the end of
phase 1 was not significantly different from the predicted
phase 1 values, had the pre-intervention rate continued (95%
CI −1.34 to 2.62; P = 0.52). However, the overall CCS
completion rate for the entirety of phase 1 was higher than
the pre-intervention rate (5.32% vs 2.90%). In phase 2, we saw
an immediate rate increase in the intercept at implementation,
a higher increase in positive slope change than the pre-
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Overall, 115 patients of the 385 identified (30%) completed
their appointments. Of those patients who completed their
appointments, 77% were African American, 14% were White,
and 9% other. The average number of Pap tests completed in
our clinic increased to 56 per month (Fig. 2), totaling 501 Pap
tests. The CCS completion index increased to 5.31% (RR,
1.86; 95% CI, 1.64–2.10; P < 0.001) (Fig. 3). Phase 1 was
difficult to sustain as it required redirecting MAs to do outreach to patients in an already under-staffed clinic.
During phase 2, which occurred during the subsequent 9
months, the number of Pap tests increased to an average of 71
per month (Fig. 2), totaling 632 Pap tests during this phase. Of
the patients who completed CCS, 474 (75%) were African
American, 93 (15%) were White, and 65 (10%) were other.
The average age was 45 years. The CCS completion index
increased further to 7.71% (RR, 2.70; 95% CI, 2.40–3.02; P <
0.001) (Fig. 3). At the end of phase 2, our clinic’s CCS rate
improved to 75%.
With both interventions, the number of completed Pap tests
increased, while the number of patients overdue for CCS
decreased (Fig. 2). The total number of eligible patients for
CCS fell from 3643 at the beginning of phase 1 to 3570 at the
end of phase 2, while the total number of patients with CCS
overdue fell from 1065 to 898 during the same time period.

2017

2018

2019
Phase 1: Outreach

Phase 2: Workﬂow Change

Figure 3 Index of completed to due Pap tests. The index of completed to due Pap tests improved throughout our interventions. Abbreviations:
Pap, Papanicolaou.
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Figure 4 Interrupted time series analysis showing immediate improvement of CCS rates in phase 1 and phase 2. Sustained improvement was
only seen in phase 2. Abbreviations: CCS, cervical cancer screening.

intervention slope increase (0.46 versus 0.12), and a higher
than predicted completion rate at the beginning of phase 2 than
if the pre-intervention trend had continued (6.04% vs 5.05%).
We performed a random chart audit of 75 patients (25 preintervention, 25 in phase 1, and 25 in phase 2). There were no
CCS performed in patients younger than 21 years of age,
greater than 65 years of age with prior appropriate screening,
or in patients with total hysterectomy. There was 1 patient in
the control group who had HPV testing at age < 30 and 0
during the intervention. There was 1 patient in the control
group and 3 patients during the intervention who had CCS
done at sooner intervals than recommended. We found that 4
Pap tests were counted in our total CCS that were ordered but
not completed (1 prior to intervention and 3 during the
intervention).

DISCUSSION

This quality improvement intervention showed a significant
increase in cervical cancer screening within our large, urban
GIM clinic during an 18-month period. We used Lean processes to identify the most prominent barriers to CCS within
our institution and developed multiple solutions that we implemented in two phases. Both phases involved a team-based
organizational change in which MAs identified patients overdue for CCS. During phase 1, we used outreach, education,
and financial incentives and observed an increase in the number of Pap tests completed. During phase 2, we used a
workflow change which led to a more significant increase in
CCS than in phase 1. Our study implemented a unique teambased approach for increasing CCS, suggesting that modest
adjustments to clinical workflow may improve CCS rates for
certain patient populations.

Phase 1 of our intervention included patient outreach, financial incentives, and provider education. Due to our academic environment, we felt that enhancing provider education
was necessary, although it is not possible to know what
amount this contributed to the increased rate. Outreach by
telephone led to an increase in CCS, but these benefits were
offset by the disadvantages of high no-show and cancellation
rates and a staffing burden incurred by having MAs make
telephone calls. Our clinic has reduced MA staffing compared
to other internal medicine clinics, with an average ratio of MA
FTE to physician FTE being 0.73, relative to 1.11 nationally.32
Thus, sustainability of phase 1 was challenging. Prior to the
initiation of phase 1, we saw an immediate increase in the CCS
rate in our clinic, which we believe may have been due to an
increased awareness of our low CCS rates. Although the
overall CCS rate was higher during phase 1 than in the preintervention period, the observed CCS rate for the end of
phase 1 was lower than the predicted rate based on preintervention trends. We believe this may have been because
the intervention was not practically sustainable. This led to the
development of our phase 2 intervention.
We found that phase 2 of our intervention, which
empowered MAs to identify patients in clinic who were overdue for CCS, was sustainable and led to a significant improvement in CCS. This intervention did not require any additional
time or resources aside from the initial education on the
workflow change. In other studies involving MA interventions, some of the greatest barriers included time pressure to
keep workflow going33 and the need for significant training.27
In contrast, our intervention helped save time by moving the
preparation for the Pap test forward in the process. Our intervention did not contribute to a significant increase in lowvalue care, and the number of referrals to OB/GYN decreased.
There were no other system changes.
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Although our CCS rate improved from 70% to 75%, we fell
short of our target of 83% which may have occurred for
several reasons. First, our CCS rate uses a 12-month rolling
average, which may have blunted the immediate effect of our
intervention. Second, this may have been due in part to a
shifting denominator of eligible patients. A total of 1144 Pap
tests were done during the 18-month intervention; however,
the number of patients overdue for CCS fell by only 167. We
postulate several possible reasons for this. First, women enter
the study cohort at age 21 and exit the study cohort at age 65,
creating a persistent change in the population. Also, women
may get a total hysterectomy or change primary care providers. We offered Pap tests to all patients regardless of
whether they had a provider within or outside our health
system. Some Pap tests are done in women over 65 or sooner
than within 3- to 5-year intervals if an abnormal test occurs.
Lastly, it was noted in our random chart audit that a small
number of CCS ordered were not completed but had been
counted in our total CCS count.
Limitations to our study included lack of a control group.
As an observational study, our findings are not generalizable
to other populations. Since we used CCS ordered as a marker
for CCS completion before and during the intervention, our
numbers may be slightly higher than the actual number of
CCS completed, since a small percentage of patients may not
have had CCS completed despite it having been ordered. We
were unable to analyze the effect of our increased CCS on
patient outcomes due to our small sample size. We did not
include patient-stakeholders in the design of our interventions.
Our future goal is to expand our organizational intervention to
other clinics within our health system to improve our health
system CCS rate.
In conclusion, we believe that our systematic organizational
intervention empowering MAs to identify and prepare patients
for CCS early in the visit could be applied in a variety of
clinical settings to help close gaps in care. We found that a
combination of outreach, financial incentives, and education
were impactful, but were less sustainable over time.
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